Materials and methods for treatment of inflammation
AssigneeCytogel Pharma, LLC
InventorsTheodore E. Maione, Constantine Basil Maglaris
Life of this patent
Estimating the term…
Abstract
The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.
Claims2
A method for treating a human subject to reduce neurogenic inflammation, wherein said method comprises administering, intravenously, to a human subject in need of treatment of neurogenic inflammation, an effective amount of the acetate salt of SEQ ID NO:13.
Dependencies are inferred from the claim text.